摘要
目的观察孟鲁司特在小儿支气管哮喘治疗中的应用价值。方法选取100例该院在2015年7月—2017年7月实施治疗的小儿支气管哮喘患儿作为研究对象,依照患者不同治疗方式将其分成两组,其中对照组患儿实施单纯普米克令舒雾化吸入治疗,观察组患儿在对照组基础上实施孟鲁司特治疗,比较两组患儿治疗后咳嗽、喘息等症状缓解时间。并对其疗效及不良反应进行观察。结果对两组支气管哮喘患儿的治疗效果进行分析,观察组患儿和对照组患儿的临床治疗显效率分别为94.0%和80.0%,差异有统计学意义(χ~2=4.320,P<0.05);两组患儿治疗后咳嗽、气喘、湿啰音等症状缓解时间均明显降低,且观察组降低更明显,差异有统计学意义(t=4.65、5.12、4.89,P<0.05)。结论小儿支气管哮喘实施孟鲁司特治疗,能够取得良好临床效果,值得推广。
Objective To observe the application value of montelukast in treatment of children with bronchial asthma.Methods 100 cases of children with bronchial asthma treated in our hospital from July 2015 to July 2017 were selected and divided into two groups according to different treatment ways, the control group were for atomization inhalation therapy of simple pulmicort respules, while the observation group were treated with montelukast on the basis of the control grouip, and the cough, asthma relief time were compared between the two groups, and the curative effect and adverse reactions were observed. Results The clinical markedly effective rate in the observation group and in the control group was respectively 94.0%, 80.0%, and the difference was statistically significant（χ^2=4.320,P〈0.05）; and the cough, asthma and moist rale relief time of the two groups obviously decreased, and the decrease degree in the observation group was more obvious, and the difference was statistically significant（t=4.65, 5.12, 4.89, P〈0.05）. Conclusion The clinical effect of montelukast in treatment of children with bronchial asthma is good, which is worth promotion.
作者
靳玉红
JIN Yu-hong(Department of Pediatrics,Qihe Maternal and Infant Healthcare Hospital,Qihe,Shandong Province,251100 China)
出处
《系统医学》
2018年第13期92-94,共3页
Systems Medicine
关键词
孟鲁司特
小儿支气管哮喘
普米克令舒
Montelukast
Children with bronchial asthma
Pulmieort respules
